Abstract
Within the biological models of behavior, there are various major themes about what determines or underlies both normal and abnormal behavior. The most widely accepted premise is that the nervous system is the center of control for all behavior. Therein lies the content of this chapter. What controls the development of the nervous system, and what elements combine to determine its state and function at any given time? To answer these questions, the following must be considered: (1) genetic determinants of the development of the nervous system, (2) how environmental factors interact with genetics to influence neural development; and (3) the dynamics of change in the developed nervous system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akbarian, S., Kim, J. J., Potkin, S. G., Hagman, J. O., Tafazzoli, A., Bunney, W. E., Jr., & Jones, E. G. (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry, 52, 267–278.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: Author.
Andreasen, N. C, Rezai, K., Alliger, R., Swayze, V. W., II, Flaum, M., Kirchner, P., Cohen, G., & O’Leary, D. S. (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry, 49, 943–958.
Andreason, N. C. (1994). Changing concepts of schizophrenia and the ahistorical fallacy. American Journal of Psychiatry, 151, 1405–1407.
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, T., and Human, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology, 42, 631–639.
Barlow, D. H. (1988). Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford.
Baron, M, Risch, N., Hamburger, R., Mandel, B., Kushner, S., Newman, M., Drumer, D., Belmaker, R. H. (1987). Genetic linkage between X-chromosome markers and bipolar affective illness. Nature, 326, 289–292.
Benes, F. M. (1993). The relationship between structural brain imaging and histopathologic findings in schizophrenia research. Harvard Review of Psychiatry, 1, 100–109.
Berman, K. F., & Weinberger, D. R. (1990). The prefrontal cortex in schizophrenia and other neuropsychiatrie diseases: In vivo physiological correlates of cognitive deficits. Progress in Brain Research, 85, 521–536.
Bierer, L. M., Hof, P. R., Purohi, D. P., Carlin, L., Schmeider, J., Davis, K. L., Perl, D. P. (1995). Neocortical neurofibrillary tangle correlate with dementia severity in Alzheimer’s disease. Archives of Neurology, 52, 81–88.
Bindra, D. A. (1970). Emotion and behavior theory: Current research in historical perspective. In P. Black (Ed.), Physiological correlates of emotion (pp. 3–20). New York: Academic.
Bird, T. D., Lampe, T. H., Wijsman, E. M., & Schellenberg, G. D. (1998). Familial Alzheimer’s disease: genetic studies. In M. F. Folstein (Ed.), Neurobiology of primary dementia. Washington, DC: American Psychiatric Press.
Breier, A., Su, T. P., Saunders, R., Carson, R. E., Kolachana, B. S., DeBartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C, & Pickar, D. (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission method. Proceedings of the National Academy of Sciences USA, 94, 2569–2574.
Breiter, H. C, Rauch, S. L., Kwong, K. K., Baker, J. R., Weisskoff, R. M., Kennedy, D. N., Kendrick, A. D., Davis, T. L., Jiang, A. P., Cohen, M. S., Stern, C. E., Belliveau, J. W, Baer, L., O’Sullivan, R. L., Savage, C. R., Jenike, M. A., & Rosen, B. R. (1996). Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Archives of General Psychiatry, 53, 595–606.
Brown, R. P., Kocsis, J. H., & Frazer A. (1985). Serum melatonin in affective disorders. American Journal of Psychiatry, 142, 811–816.
Bunney, W. E., Jr., & Davis, J. M. (1965). Norepinephrine in depressive reactions: A review. Archives of General Psychiatry, 13, 483–494.
Cannon, W. B. (1920). Bodily changes in pain, fear, and rage. New York: Appleton.
Cardoret, R. J., & Winokur, G. (1975). X-linkage in manic-depressive illness. Annual Review of Medicine, 26, 21–25.
Cartwright, R. D., & Wood, E. (1991). Adjustment disorders of sleep: The sleep effects of a major stressful event and its resolution. Psychiatry Research, 39, 199–209.
Cassens, G., Wolfe, L., & Zola, M. (1990). The neuropsychology of depression. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 202–213.
Cichon, S., Noethen, N. M, Catalano, M., Di Bella, D., et al. (1995). Identification of two novel polymorphisms and a rare deletion variant in the human dopamine D4 receptor gene. Psychiatric Genetics, 5(3), 97–103.
Conrad, A. J., Abebe, T., Austin, R., Forsythe, S., & Scheibel, A. B. (1991). Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry, 48, 413–417.
Crow, T. J. (1991). The search of the psychosis gene. British Journal of Psychiatry, 158, 611–614.
Crow, T. J., Delisi, L. E., Lofthouse, R., Poulter, M., Lehner, T., Bass, N., Shah, T., Walsh, C, Boccio-Smith, A., & Shields, G. (1994). An examination of linkage of schizophrenia and schizoaffective disorder to the pseudoauto-somal region (Xp22.3). British Journal of Psychiatry, 164, 159–164.
Curtis, G. C, Nesse, R., Buxton, M., & Lippman, D. (1979). Plasma growth hormone: Effect of anxiety during flooding in vivo. American Journal of Psychiatry, 136(4-A), 410–414.
Curtis, G. C, Nesse, R. M, Buxton, M, & Lippman, D. (1979). Plasma growth hormone: Effect of anxiety during flooding in vivo. American Journal of Psychiatry, 136, 410–414.
Dalack, G. W., Glassman, A. H., Rivelli S., Covey, L., & Stetner, F. (1995). Mood, major depression, and fluoxetine response in cigarette smokers. American Journal of Psychiatry, 752(3), 398–403.
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991). Dopamine in schizophrenia: A review and reconceptualization. American Journal of Psychiatry, 148, 1474–1486.
Dickson, D. W, Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D, Davies, P., Yen, S. H., & Arson, M. K. (1992). Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiology of Aging, 13, 179–189.
Dilsaver, S. C. (1986). Cholinergic mechanisms in depression. Brain Research Reviews, 11(3), 285–316.
Duman, R. S. (1998). Novel therapeutic approaches beyond the serotonin receptor. Biological Psychiatry, 44(5), 324–335.
Egeland, J. A., Gerhard, D. S., Pauls, D. L., Sussex, J. N., et. al. (1987). Bipolar affective disorder linked to DNA markers on chromosome 11. Nature, 325(6101), 783–787.
Ehlers, A., Margraf, J., Roth, W. T., Taylor, C. B., Maddock, R. J., Sheik, J., Kobell, M. L., McClenahan, K. L., Gossard, D., Blowers, G. H., Agras, W. S., & Kopell, B. S. (1986). Lactate infusions and panic attacks: Do patients and controls respond differently? Psychiatry Research, 17, 295–308.
Forstl, H., & Levy, R. (1991). Foreword to the translation of“On certain peculiar diseases of old age” (by Alois Alzheimer). History of Psychiatry, ii, 71–74.
Goedert, M., Wischik, C. M, Crowther, R. A., Walker, J. E., & Klug, A. (1988). Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer’s disease: Identification as the microtubule-associated protein tau. Proceedings of the National Academy of Sciences USA, 85, 4051–4055.
Goldman-Rakic, P. S. (1996). Dissolution of cerebral cortical mechanisms in subjects with schizophrenia. In S. J. Watson (Ed.), Biology of schizophrenia and affective disease (pp. 113–128). Washington, DC: American Psychiatric Press.
Golomb, J., deLeon, M. J., George, A. E., Kluger, A., Convit, A., Rusinek, H., deSanti, S., Litt, A., Foo, S. H., & Ferris, S. H. (1994). Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus. Journal of Neurology, Neurosurgery and Psychiatry, 57, 590–593.
Gooding, D., & lacono, W. (1995). Schizophrenia through the lens of a developmental psychopathology perspective. In Developmental psychopathology, Vol. 2: Risk, disorder, and adaptation. Wiley Series on Personality Processes (pp. 535–580). New York: Wiley.
Gottesman, I. L. (1995). Schizophrenia genes: The origins of madness. New York: Freeman.
Grahme-Smith, D. G., Green, A. R., & Costain, D. W. (1978). Mechanism of the anti-depressant action of electroconvulsive therapy. Lancet, 1, 254–256.
Green, A. R. (1978). ECT—How does it work? Trends in Neuroscience, 1, 53–54.
Haass, C, Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C, Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., & Selkoe, D. (1992). Amyloid beta peptide is produced by cultured cells during abnormal metabolism. Nature, 359, 322–325.
Hall, M. H., Dahl, R. E., Dew, M. A., & Reynolds, C. F. (1995). Sleep patterns following major negative life events. Directions in Psychiatry, 15, 1–10.
Hyde, T. M., & Weinberger, D. R. (1990). The brain in schizophrenia. Seminars in Neurology, 10, 276–286.
Imamura, M., & Prasad, C. (1998). Increased GABA-gated chloride ion influx in the hypothalamus of low anxiety rats. Physiological Behavior, 64(3), 415–417.
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Körten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992). Schizophrenia: Manifestations, incidence, and course in different cultures. Psychological Medicine, Monograph Supplement, 20.
James, W. (1884). What is emotion? Mind, 9(Series I), 188–204.
Kagan, J. (1997). Temperament and the reactions to unfamiliarity. Child Development, 68, 139–143.
Kalin, N. H., Dawson, G., Traiot, P., Shelton, S., Barksdale, C, Weiler, S., & Thienemann, M. (1987). Function of the adrenal cortex in patients with major depression. Psychiatry Research, 22, 117–125.
Kemali, D., Galderisi, M. S., Ariano, M. G., Cesarelli, M., Milici, N., Salvati, A., Valente, A., & Volpe, M. (1985). Clinical and neuropsychological correlates of cerebral ventricular enlargement in schizophrenia. Journal of Psychiatric Research, 19, 587–596.
Kety, S.S. (1983). Mental illness in the biological and adoptive families of schizophrenic adoptees: Findings relevant to genetic and environmental factors in etiology. American Journal of Psychiatry, 140, 720–727.
Kety, S. S., Wender, P. H., Jacobsen, B., Ingraham, L. J., Jansson, L., Faber, B., & Kinney, D. K. (1994). Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen study in the rest of Denmark. Archives of General Psychiatry, 51, 442–455.
Kovelman, J. A., & Scheibel, A. B. (1984). A neurohistological correlate of schizophrenia. Biological Psychiatry, 19, 1601.
Lacey, J. I., & Lacey, B. C. (1970). Some autonomie-central nervous system interrelationships. In P. Black (Ed.), Physiological correlates of emotion. New York: Academic.
Lampe, T. H., Bird, T. D., Nochlin, D., Nemens, E., Risse, S. C, Sumi, S. M., Koerker, R., Leaird, B., Wier, M., & Raskind, M. A. (1994). Phenotype of chromosome 14-linked familial Alzheimer’s disease in a large kindred. Annals of Neurology, 36, 368–378.
Lang, P. J. (1995). The emotion probe: Studies of motivation and attention. American Psychologist, 50(5), 372–385.
Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A., Weber, J. L., Bird, T. D., & Schellenberg, G. D. (1995). A familial Alzheimer’s disease locus on chromosome 1. Science, 269, 970–973.
Loosen, P. T. (1985). The TRH-induced TSH response in psychiatric patients: A possible neuroendocrine marker. Psychoneuroendocrinology, 10, 237–260.
Loosen, P. T., & Prange A. J., Jr. (1982). Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: A review. American Journal of Psychiatry, 139, 405–416.
Machon, R. A., Mednick, S. A., & Huttunen, M. O. (1997). Adult major affective disorder after prenatal exposure to an influenza epidemic. Archives of General Psychiatry, 54, 322–328.
Mann, J. J., & Stanley, M. (Eds.). (1986). Psychobiology of suicidal behavior. Annals of the New York Academy of Science, 487, 1–357.
Mann, J. J., & Kupfer, D. J. (Eds.). (1993). Biology of depressive disorders, Part A: A systems perspective. In The depressive illness (p. 272). New York: Plenum.
Marx, J. L. (1985). “Anxiety peptide” found in brain. Science, 227, 934.
Mednick, S. A., Huttunen, M. O., & Machon, R. A. (1994). Prenatal influenza infections and adult schizophrenia. Schizophrenia Bulletin, 20, 263–267.
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., van Belle, G., & Berg, L. (1991). The consortium to establish a registry for Alzheimer’s disease. Neurology, 41, 479–486.
Moldin, S. O., Reich, T., & Rice, J. P. (1991). Current perspectives on the genetics of unipolar depression. Behavior Genetics, 21, 211–242.
Morris, R. G. (1996). The cognitive neuropsychology of Alzheimer-type dementia. Oxford, England: Oxford University Press.
Nemeroff, C. B. (1996). The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. Molecular Psychiatry, 1(4), 336–342.
Ockel, M., Lewin, G. R., & Barde, Y.A. (1996). In vivo effects of neurotrophin-3 during sensory neurogenesis. Development, 122(1), 301–307.
Oppenheim, R. W. (1991). Cell death during development of the nervous system. Annual Review of Neuroscience, 14, 453–501.
Owens, M. J., & Nemeroff, C. B. (1994). The role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clinical Chemistry, 40, 288–295.
Redmond, D. E. (1979). New and old evidence for the involvement of a brain norepinephrine system in anxiety. In W. E. Fann, I. Karacan, & A. Pokorny (Eds.), Phenomenology and the treatment of anxiety (pp. 152–203). New York: SP Medical and Scientific Books.
Reynolds, C. F., & Kupfer, D. J. (1987). Sleep research in affective illness: State of the art circa. Sleep, 10(3), 199–215.
Rocca, W. A., Hofman, A., Brayne, C, Breteler, M. M., Clarke, M., Copeland, J. R., Dartigues, J. F., Engedal, K., Hagneil, O., Heeren, T. J., et al. (1991). The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies. Annals of Neurology, 30, 817–824.
Rosenzweig, M. R., Leiman, A. L., & Breedlove, S. M. (1999). Biological psychology: An introduction to behavioral, cognitive, and clinical neuroscience. Sunderland, MA: Sinaur Associates.
Roses, A. D. (1994). Apolipoprotein E affects the rate of Alzheimer disease expression: J-Amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. Journal of Neuwpathology and Experimental Neurology, 53, 429–437.
Rubin, R. T. (1989). Pharmacoendocrinology of major depression. European Archives of Psychiatry and Neurological Sciences, 238(5-6), 259–267.
Rubin, R. T., Ananth, J., Villanueva-Meyer, J., Trajmar, P. G., & Mena, I. (1995). Regional 133 Xenon cerebral blood flow and cerebral 99m Tc-HM-PAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biological Psychiatry, 38, 429–437.
Rubin, R. T., Poland, R. E., Lesser, I. M., & Martin, D. J. (1989). Neuroendocrine aspects of primary endogenous depression: V. Serum prolactin measures in patients and matched control subjects. Biological Psychiatry, 25(1), 4–21.
Saeb, J. P., Jagust, W. J., Wong, S. T. S., et al. (1988). Quantitative NMR measurements of hippocampal atrophy in Alzheimer’s disease. Magnetic Resonance Imaging, 8, 200–208.
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. American Journal of Psychiatry, 139, 471–475.
Schildkraut, J. J., & Kety, S. S. (1967). Biogenic amines and emotion. Science, 156, 21–30.
Schwartz, M. W., Peskind, E., Raskind, M., Boyoko, E. J., & Porte, D. (1996). Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Medicine, 2, 589–593.
Seeman, P., Guan, H. C, & Van Tol, H. H. (1993). Dopamine D4 receptors elevated in schizophrenia. Nature, 365, 441–445.
Selye, H. (1978). The stress of life. New York: McGraw-Hill.
Siever, L. J., & Uhde, T. W. (1984). New studies and perspectives on the noradrenergic receptor system in depression: Effects of the alpha-2 adrenergic agonist clonidine. Biological Psychiatry, 142, 184–187.
Shields, J. (1962). Monozygotic twins brought up apart and brought up together. London: Oxford University Press.
Siever, L. J., & Davis, K. L. (1985). Overview: Toward a dysregulation hypothesis of depression. American Journal of Psychiatry, 142(9), 1017–1031.
Slater, B., & Shields, J. (1969). Genetical aspects of anxiety. In British Journal of Psychiatry Special Publication No. 3: Studies of Anxiety. Ashford, Kent: Headly Bros.
Slater, E., & Roth, M. (1960). Clinical Psychiatry, 1st ed. London: Bailliere, Tindall, and Cassel.
Smith, R., Cubis J., Brinsmead, M., Lewin, T., Singh, B., Ownes, P., Chan, E. C, Hall, C, Adler, R., Lovelock, M., Hurt, D., Rowley, M., & Nolan, M. (1990). Mood changes, obstetric experiences and alterations in plasma Cortisol, beta-endorphin and corticotrophin releasing hormone during pregnancy and the puerperium. Journal of Psychosomatic Research, 34(1), 53–69.
St. George-Hyslop, P. H. (1993). Recent advances in the molecular genetics of Alzheimer’s disease. Neuroscience, 1, 171–175.
St. George-Hyslop, P. H., Tanzi, R. E., Polinsky, R. J., Haines, J. L., Nee, L., Watkins, P. C, Meyers, R. H., Feldman, R. G., Pollen, D., Drachman, D., Growdon, J., Bruni, A., Jean-Francois, F., Salmon, D., Frommelt, P., Amaducci, L., Sorbi, S., Piacentini, S., Stewart, G. D., Hobbs, W. J., Conneally, M., & Gusella, J. F. (1987). The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science, 235, 885–890.
Stokes, P. E. (1995). The potential role of excessive Cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharmacology, 5(Suppl.), 77–82.
Swedo, S. E., Leonard, H. L., Kraesi, M. J. P., Rettew, D. C, Listwak, S. J., Berrettini, W., Stipetic, M., Hamburger, S., Gold, P. W., Potter, W. Z., & Rapoport, J. L. (1992). CSF neurochemistry in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 49, 29–36.
Thinakaran, G., Regard, J. B., Bouton, C. M., Harris, C. L., Price, D. L., Borchelt, D. R., & Sisodia, S. S. (1998). Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiology of Disease, 4, 438–453.
Torrey, E. F., Bowler, A. E., Taylor, E. H., & Gottesman, 1.1. (1994). Schizophrenia and manic depressive disorder. New York: Basic Books.
Trimble, M. R. (1996). Schizophrenia. In Biological psychiatry (pp. 183–225). New York: Wiley.
Tsuang, M. T. (1993). Genotypes, phenotypes, and the brain. British Journal of Psychiatry, 163, 299–307.
Ungerstedt, U. (1979). Central dopamine mechanisms and unconditioned behaviour. In A. S. Horn, J. Korf, & B. H. C. Westerink (Eds.), The neurobiology of dopamine (pp. 577–596). New York: Academic.
Van Bockstaele, E. J. (1998). Morphological substrates underlying opoiod, epinephrine and gamma-aminobutyric acid inhibitory actions in rat locus coeruleus. Brain Research Bulletin, 47, 1–15.
Wainer, B. H., Steininger, T. L., Roback, J. D., Burke-Watson, M. A., Mufson, E. J., & Kordower, J. (1993). Ascending cholinergic pathways: Functional organization and implications for disease models. Progress in Brain Research, 98, 9–30.
Watson, S. J. (1996). Biology of schizophrenia and affective disease. Washington, D.C.: American Psychiatric Press.
Weinberger, D. R., Aloia, M. S., Goldberg, T. E., & Berman, K. F. (1994). The frontal lobes and schizophrenia. Journal of' Neuropsychiatry and Clinical Neurosciences, 6, 419–427.
Wible, C. C, Shenton, M. E., Hokama, H., Kikinis, R., Jolesz, F. A., Metcalf, D., & McCarley, R. W. (1995). Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study. Archives of General Psychiatry, 52, 279–288.
Wilson, J. (1988). Anxiety disorders: Current treatments and controversies. Paper presented at Annual Convention of the American Psychological Association, Atlanta, GA, August, 1988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Montgomery, D.D., Planthara, P.M. (2001). Biological Model. In: Hersen, M., Van Hasselt, V.B. (eds) Advanced Abnormal Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8497-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8497-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4631-9
Online ISBN: 978-1-4419-8497-5
eBook Packages: Springer Book Archive